References
- Kurani N, Ortaliza J, Wager E, Fox L, Amin K. How has US spending on healthcare changed over time? Peterson-KFF health system tracker; 2022. Available from: https://www.healthsystemtracker.org/chart-collection/u-s-spending-healthcare-changed-time/#Contribution%20to%20change%20in%20total%20national%20health%20expenditures,%20from%202019-2020,%20by%20spending%20category. Accessed June 13, 2022.
- IBM Watson Health Research Brief. Hospital-acquired conditions lead to avoidable cost and excess deaths; 2018. Available from: https://www.ibm.com/downloads/cas/X97QXLER. Accessed June 3, 2022.
- Patel J. Heart failure population health considerations. Am J Manag Care. 2021;27(suppl 9):S191–S5.
- Khan SU, Khan MZ, Alkhouli M. Trends of clinical outcomes and healthcare resource use in heart failure in the United States. J Am Heart Assoc. 2020;9:e016782. doi:10.1161/JAHA.120.016782
- Heidenreich PA, Fonarow GC, Opsha Y, Sandhu AT, Sweitzer NK, Warraich HJ. Economic issues in heart failure in the United States. J Card Fail. 2022;28:453–466. doi:10.1016/j.cardfail.2021.12.017
- Tada A, Omote K, Nagai T, et al. Prevalence, determinants, and prognostic significance of hospital acquired pneumonia in patients with acute heart failure. J Clin Med. 2020;9:2219. doi:10.3390/jcm9072219
- Greene SJ, Triana TS, Ionescu-Ittu R, et al. In-Hospital therapy for heart failure with reduced ejection fraction in the United States. JACC Heart Fail. 2020;8:943–953. doi:10.1016/j.jchf.2020.05.013
- Mullens W, Damman K, Harjola V-P, et al. The use of diuretics in heart failure with congestion – a position statement from the heart failure association of the European Society of Cardiology. Eur J Heart Fail. 2019;21:137–155. doi:10.1002/ejhf.1369
- Greene SJ, Mentz RJ, Fleker M. Outpatient worsening heart failure as a target for therapy: a review. JAMA Cardiol. 2018;3:252–259. doi:10.1001/jamacardio.2017.5250
- Agency for Healthcare Research and Quality HCUPNet Healthcare Cost and Utilization Project Hospital Inpatients National Statistics. National diagnoses – Clinical Classification Software Refined (CCSR), principal diagnosis: CIR019 heart failure; 2018. Available from: hcupnet.ahrq.gov. Accessed October 6, 2022.
- US Department of Health and Human Services Office for Human Research Protections. Human subject regulations decision charts. Available from https://www.hhs.gov/ohrp/regulations-and-policy/decision-charts/index.html. Accessed February 20, 2023. Accessed February 3, 2022.
- Akintoye E, Briasoulis A, Egbe A, et al. National trends in admission and in-hospital mortality of patients with heart failure in the United States (2001–2014). J Am Heart Assoc. 2017;6:e006955. doi:10.1161/JAHA.117.006955
- American Heart Association. American Heart Association get with the guidelines – heart failure HF factsheet; 2016. Available from: https://www.heart.org/idc/groups/heart-public/@wcm/@hcm/@gwtg/documents/downloadable/ucm_467882.pdf. Accessed October 2, 2021.
- Presley CS, Min JY, Chipman J, et al. Validation of an algorithm to identify heart failure hospitalisations in patients with diabetes within veterans health administration. BMJ Open. 2018;8:e020455. doi:10.1136/bmjopen-2017-020455
- Overview of the National (Nationwide) Inpatient Sample (NIS). Available from: https://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed September 28, 2021.
- Pickens GT, Liang L, Roemer M HCUP cost-to-charge ratio methodologies. 2021. HCUP methods series report # 2021-05 ONLINE; 2021. U.S. Agency for Healthcare Research and Quality. Available from: http://www.hcupus.ahrq.gov/reports/methods/methods.jsp. Accessed October 1, 2022.
- Centers for Medicare and Medicaid Services. FY 2022 IPPS final rule home page. Available from: https://www.cms.gov/medicare/acute-inpatient-pps/fy-2022-ipps-final-rule-home-page#Tables. Accessed October 12, 2022.
- Urbich M, Globe G, Pantiri K, Heisen M, Bennison C, Wirtz HS. A systematic review of medical costs associated with heart failure in the USA (2014–2020). Pharmacoeconomics. 2020;38:1219–1236. doi:10.1007/s40273-020-00952-0